Biotech Acquisition Co
NASDAQ:BIOT
Biotech Acquisition Co
Cash from Financing Activities
Biotech Acquisition Co
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Biotech Acquisition Co
NASDAQ:BIOT
|
Cash from Financing Activities
$231.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WP Carey Inc
NYSE:WPC
|
Cash from Financing Activities
-$393.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-3%
|
|
Starwood Property Trust Inc
NYSE:STWD
|
Cash from Financing Activities
-$2.7B
|
CAGR 3-Years
-555%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Cash from Financing Activities
$2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Cash from Financing Activities
$672m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
-6%
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Cash from Financing Activities
$10.9B
|
CAGR 3-Years
134%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biotech Acquisition Co's Cash from Financing Activities?
Cash from Financing Activities
231.6m
USD
Based on the financial report for Dec 31, 2021, Biotech Acquisition Co's Cash from Financing Activities amounts to 231.6m USD.